Your search returned 6 results.

Sort
Results
1.
Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis. [Review] MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 33942167
Year: 2021
Citation:
  • Annals of Surgical Oncology. 28(12):7109-7117, 2021 Nov.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Chang D, Sugarbaker PH
2.
Importance of gender in diffuse malignant peritoneal mesothelioma. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 22056853
Year: 2012
Citation:
  • Annals of Oncology. 23(6):1494-8, 2012 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
  • Multicenter Study
Form of publication:
  • Journal Article
All authors:
  • Cao C, Chua TC, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Peritoneal Surface Malignancy Group, Piso P, Sugarbaker PH, Yan TD
3.
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 22495719
Year: 2012
Citation:
  • Tumori. 98(1):166-71, 2012 Jan-Feb.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Comparative Study
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Alexander R, Bayon LG, Cao C, Deraco M, Esquivel J, Gertsch P, Glehen O, Gonzalez-Moreno S, Kecmanovic D, Larsen SG, Laurberg S, Levine EA, Link K, Mahteme H, Melero JT, Moran B, Morris DL, Piso P, Sugarbaker PH, Tentes AA, van der Speeten K, Yan TD
4.
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 29260418
Year: 2018
Citation:
  • Annals of Surgical Oncology. 25(3):667-673, 2018 Mar.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Baratti D, Chouliaras K, De Simone M, Deraco M, Elias D, Glehen O, Heyd B, Kusamura S, Levine EA, Morris D, RENAPE Working Group, Robella M, Russell G, Shen P, Sugarbaker P, Votanopoulos KI
5.
Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. MedStar authors:
  • Bijelic, Lana
  • Ihemelandu, Chukwuemeka
  • Sugarbaker, Paul H
PMID:
  • 25120250
Year: 2015
Citation:
  • Annals of Surgical Oncology. 22(5):1680-5, 2015 May.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bijelic L, Ihemelandu C, Sugarbaker PH
6.
Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma. [Review] MedStar authors:
  • Jelinek, James S
  • Sugarbaker, Paul H
PMID:
  • 33888394
Year: 2021
Citation:
  • European Journal of Surgical Oncology. 47(9):2212-2219, 2021 Sep.
Institution:
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Radiology
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Chang D, Jelinek JS, Sugarbaker PH
Pages

Powered by Koha